Cargando…

A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies

Broadly neutralizing antibodies (bNAbs) can prevent and control an HIV-1 infection, but their breadth is invariably too limited for use as monotherapy. To address this problem, bi- and trispecific antibody-like constructs have been developed. These engineered antibodies typically have greater breadt...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis-Gardner, Meredith E., Alfant, Barnett, Weber, Jesse A., Gardner, Matthew R., Farzan, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6960291/
https://www.ncbi.nlm.nih.gov/pubmed/31937648
http://dx.doi.org/10.1128/mBio.03080-19